Clinical trial
D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia
NCT00237848 · Yale University, Other · Completed
Key facts
| NCT number | NCT00237848 |
|---|---|
| Title | D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia |
| Official title | D-Serine Augmentation of Cognitive Retraining in Schizophrenia |
| Lead sponsor | Yale University, Other |
| Collaborators | Stanley Medical Research Institute Donaghue Foundation US Department of Veterans Affairs U.S. Fed VA Office of Research and Development |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | D-serine, Cognitive retraining |
| Enrollment | 72 |
| Start date | Feb 1, 2005 |
| First posted | Oct 12, 2005 |
| Last update posted | Jun 18, 2012 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: